Integer (NYSE:ITGR) Issues Quarterly Earnings Results

Integer (NYSE:ITGR) issued its earnings results on Thursday. The medical equipment provider reported $1.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.70 by $0.06, Briefing.com reports. The business had revenue of $472.06 million during the quarter, compared to the consensus estimate of $462.73 million. Integer had a return on equity of 12.84% and a net margin of 4.75%.The company’s revenue for the quarter was up 5.0% on a year-over-year basis. During the same period last year, the company earned $1.43 EPS. Integer updated its FY 2026 guidance to 6.290-6.780 EPS.

Here are the key takeaways from Integer’s conference call:

• Integer delivered a strong FY‑2025 beat with sales up 8% reported (6% organic), adjusted EPS up 21%, expanded adjusted operating margin ~76 bps, and repurchased $50M in Q4 while announcing a ~$50M accelerated share repurchase.
• The 2026 outlook was narrowed and includes an expected 3%–4% headwind from three new products (two in electrophysiology, one in neuromodulation) that had lower‑than‑expected market adoption, driving flat to +3% organic sales guidance and near‑term margin pressure (Q1 operating margin down ~200–250 bps year‑over‑year).
• Capital and cash generation remain solid — FY‑2025 free cash flow was $105M, net total debt is ~$1.19B (3.0x trailing EBITDA), management reaffirmed disciplined capital allocation with continued M&A and buybacks and expects 2026 free cash flow of $100M–$120M.
• Management highlights a diversified, high‑value pipeline (about 40 CRM&N development customers) and expects PMA‑related customers to grow ~15%–20% CAGR over 3–5 years and aims to return to 200 bps above‑market organic growth with margin expansion by 2027, though this is forward‑looking and contingent on product launches.

Integer Trading Down 0.5%

NYSE ITGR traded down $0.40 during trading on Thursday, hitting $86.08. The stock had a trading volume of 988,155 shares, compared to its average volume of 752,522. The company has a quick ratio of 2.45, a current ratio of 3.71 and a debt-to-equity ratio of 0.70. The company has a market capitalization of $3.02 billion, a PE ratio of 36.32, a PEG ratio of 0.81 and a beta of 0.77. The firm has a 50 day moving average price of $82.37 and a 200 day moving average price of $88.44. Integer has a twelve month low of $62.00 and a twelve month high of $144.76.

Analyst Upgrades and Downgrades

ITGR has been the subject of several analyst reports. Raymond James Financial reissued an “outperform” rating and issued a $95.00 price target (down previously from $143.00) on shares of Integer in a research note on Friday, October 24th. Piper Sandler cut their target price on Integer from $155.00 to $82.00 and set an “overweight” rating for the company in a research note on Friday, October 24th. Benchmark restated a “hold” rating on shares of Integer in a research report on Friday, October 24th. Wells Fargo & Company reiterated an “equal weight” rating and set a $80.00 price target (down from $132.00) on shares of Integer in a report on Friday, October 24th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of Integer in a research report on Monday, December 29th. Four analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $98.38.

Integer declared that its Board of Directors has approved a share repurchase plan on Tuesday, November 4th that permits the company to buyback $200.00 million in shares. This buyback authorization permits the medical equipment provider to repurchase up to 8.3% of its stock through open market purchases. Stock buyback plans are often a sign that the company’s board of directors believes its stock is undervalued.

Hedge Funds Weigh In On Integer

Several institutional investors have recently modified their holdings of ITGR. Van ECK Associates Corp raised its holdings in shares of Integer by 116.9% in the 4th quarter. Van ECK Associates Corp now owns 3,095 shares of the medical equipment provider’s stock valued at $243,000 after purchasing an additional 1,668 shares in the last quarter. Lido Advisors LLC increased its holdings in Integer by 5.5% in the fourth quarter. Lido Advisors LLC now owns 2,887 shares of the medical equipment provider’s stock valued at $226,000 after buying an additional 151 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its holdings in Integer by 113.2% in the third quarter. Northwestern Mutual Wealth Management Co. now owns 1,475 shares of the medical equipment provider’s stock valued at $152,000 after buying an additional 783 shares during the last quarter. State of Wyoming acquired a new stake in Integer in the second quarter valued at $233,000. Finally, Vident Advisory LLC purchased a new stake in Integer during the 2nd quarter worth about $218,000. Institutional investors and hedge funds own 99.29% of the company’s stock.

Key Stories Impacting Integer

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Q4 earnings beat — Integer reported $1.76 EPS vs. the Zacks/consensus $1.70 estimate and up from $1.43 a year ago, showing margin/earnings improvement. Integer (ITGR) Surpasses Q4 Earnings and Revenue Estimates
• Positive Sentiment: Revenue and full-year performance — Q4 revenue rose ~5% YoY; full-year 2025 delivered ~8% sales growth and ~21% adjusted EPS growth, which supports the bullish reaction. Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2025
• Positive Sentiment: Guidance largely in line to slightly above consensus — FY2026 EPS guidance of $6.29–$6.78 and revenue guidance of $1.8–$1.9B maintains the company’s prior outlook (management highlights keeping the midpoint of sales growth and the high end of adjusted EPS growth). That stability helped investor confidence. Integer FY2026 Guidance and Outlook
• Neutral Sentiment: Guidance nuance — the EPS range’s lower bound (6.29) is marginally below some consensus points (~6.31) while the high end is well above; investors will watch quarterly cadence and margin drivers to judge whether the company hits the high end. Integer Q4 Earnings: Key Metrics Versus Estimates
• Neutral Sentiment: Management materials available — the company posted a press release, slide deck and conference-call transcript for deeper detail; active investors should review the call/slides for margin, backlog and expected product/customer contributions. Listen to Conference Call / View Slide Deck

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.